This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Tokushima University, Nagoya University. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: Takako Izumoto: Innovator in Tissue Repair Technology
Introduction
Takako Izumoto is a prominent inventor based in Nagoya, Japan. She has made significant contributions to the field of tissue repair through her innovative research and patented compositions. With a total of 3 patents, her work focuses on enhancing tissue repair mechanisms, which has important implications for medical science.
Latest Patents
Izumoto's latest patents include a composition that possesses tissue-repairing activity. This composition is designed to promote reactions associated with tissue repair and contains several key components. These include a protein with monocyte chemotactic protein-1 (MCP-1) activity, a protein with the extracellular domain activity of sialic acid-binding immunoglobulin-type lectin-9 (Siglec-9), and at least one of chondroitin sulfate or chondroitin sulfate proteoglycan. This innovative approach to tissue repair showcases her commitment to advancing medical treatments.
Career Highlights
Throughout her career, Takako Izumoto has worked at esteemed institutions such as Tokushima University and Nagoya University. Her research has not only contributed to her own patents but has also influenced the broader scientific community. Her dedication to her work has established her as a respected figure in her field.
Collaborations
Izumoto has collaborated with notable colleagues, including Akihito Yamamoto and Minoru Ueda. These partnerships have further enriched her research and have led to advancements in the understanding of tissue repair mechanisms.
Conclusion
Takako Izumoto's innovative work in tissue repair technology highlights her role as a leading inventor in her field. Her contributions through her patents and collaborations continue to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

